| N-[1-(3-Amino-3-oxopropyl)-5-[benzoyl(methyl)amino]benzimidazol-2-yl]-4-cyanobenzamide | IC50 | 17.0 [1] |
| N-[1-(3-Aminopropyl)-5-[cyclohexanecarbonyl(methyl)amino]benzimidazol-2-yl]thiophene-2-carboxamide | IC50 | 25.0 [1], 110.0 [2], 320.0 [3], 1600.0 [4], 5000.0 [5] |
| N-[1-(3-Amino-3-oxopropyl)-5-[benzoyl(methyl)amino]benzimidazol-2-yl]thiophene-2-carboxamide | IC50 | 14.0 [1], 25.0 [2], 58.0 [3], 2400.0 [4], 2700.0 [5] |
| Ibrutinib | IC50 | 10.7 [1], 11.7 [2], 13.9 [3] |
| N-[5-[[3-(4-Acetylpiperazine-1-carbonyl)-4,5-dimethylphenyl]methylsulfanyl]-1,3-thiazol-2-yl]-4-[(3,3-dimethylbutan-2-ylamino)methyl]benzamide | IC50 | 90.0 [1], 96.0 [2], 650.0 [3], 700.0 [4] |
| 3-[4-Amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(3-methyl-4-propan-2-ylphenyl)benzamide | IC50 | 2.0 [1], 31.0 [2], 48.0 [3] |
| N-[1-(3-Amino-3-oxopropyl)-5-[benzoyl(methyl)amino]benzimidazol-2-yl]-4-chlorobenzamide | IC50 | 6.0 [1], 18.0 [2], 340.0 [3], 1300.0 [4] |
| N-[1-[(1S)-3-(Dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide | IC50 | 25.0 [1], 173.0 [2] |
| N-[1-[(1S)-3-(Dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide | Ki | 0.1 [1] |
| N-[1-(3-Cyanobenzyl)-1h-Pyrazol-4-Yl]-6-(1h-Pyrazol-4-Yl)-1h-Indazole-3-Carboxamide | IC50 | 210.0 [1], 231.0 [2] |
| N-[1-(3-Cyanobenzyl)-1h-Pyrazol-4-Yl]-6-(1h-Pyrazol-4-Yl)-1h-Indazole-3-Carboxamide | Ki | 0.8 [1], 1.1 [2] |
| N-(1-Benzylpyrazol-4-yl)-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | IC50 | 5200.0 [1] |
| N-(1-Benzylpyrazol-4-yl)-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | Ki | 5.3 [1] |
| N-(1-Benzylpyrazol-4-yl)-5a-methyl-4,4a,5,6-tetrahydro-1H-cyclopropa[f]indazole-3-carboxamide | IC50 | 410.0 [1] |
| N-(1-Benzylpyrazol-4-yl)-5a-methyl-4,4a,5,6-tetrahydro-1H-cyclopropa[f]indazole-3-carboxamide | Ki | 3.0 [1], 200.0 [2] |
| 6,6-Dimethyl-N-[1-[(1S)-3-methylsulfonyl-1-phenylpropyl]pyrazol-4-yl]-1,4,5,7-tetrahydroindazole-3-carboxamide | IC50 | 310.0 [1] |
| 6,6-Dimethyl-N-[1-[(1S)-3-methylsulfonyl-1-phenylpropyl]pyrazol-4-yl]-1,4,5,7-tetrahydroindazole-3-carboxamide | Ki | 6.2 [1] |
| 3-[4-Amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-[(4-tert-butylphenyl)methyl]benzamide | IC50 | 10.0 [1], 516.0 [2], 6731.0 [3] |
| 2-PropenaMide, N-[cis-4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]cyclohexyl]- | IC50 | 909.9 [1], 1954.0 [2] |
| Staurosporine | IC50 | 4.02 [1], 12.81 [2], 16000.0 [3] |
| N-[1-(2-Hydroxy-2-methylpropyl)-5-(morpholin-4-ylmethyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 2.0 [1], 13.0 [2], 220.0 [3] |
| N-[1-(3-Amino-3-oxopropyl)-5-[cyclohexanecarbonyl(methyl)amino]benzimidazol-2-yl]-4-cyanobenzamide | IC50 | 4.0 [1], 300.0 [2] |
| N-[1-(3-Amino-3-oxopropyl)-5-[benzoyl(methyl)amino]benzimidazol-2-yl]benzamide | IC50 | 3.0 [1], 180.0 [2], 2300.0 [3] |
| N-[1-(3-Amino-3-oxopropyl)-5-[benzoyl(methyl)amino]benzimidazol-2-yl]-1,2-oxazole-5-carboxamide | IC50 | 10.0 [1], 100.0 [2], 5000.0 [3] |
| N-[1-(3-Amino-3-oxopropyl)-5-[benzoyl(methyl)amino]benzimidazol-2-yl]-5-cyanothiophene-2-carboxamide | IC50 | 8.0 [1], 15.0 [2], 150.0 [3] |
| N-[1-(3-Cyanobenzyl)-1h-Pyrazol-4-Yl]-2h-Indazole-3-Carboxamide | IC50 | 4600.0 [1] |
| N-[1-(3-Cyanobenzyl)-1h-Pyrazol-4-Yl]-2h-Indazole-3-Carboxamide | Ki | 15.0 [1], 43.0 [2] |
| N-[1-[(1S)-3-(Dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | IC50 | 45.0 [1], 55.0 [2] |
| N-[1-[(1S)-3-(Dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | Ki | 0.7 [1] |
| N-[5-[[[(2S)-3,3-Dimethylbutan-2-yl]amino]methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 1.0 [1], 4.0 [2], 13.0 [3] |
| N-[5-[Benzoyl(methyl)amino]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(2-methyl-1,3-oxazol-5-yl)thiophene-2-carboxamide | IC50 | 3.0 [1], 110.0 [2], 200.0 [3] |
| N-[1-(2-Hydroxy-2-methylpropyl)-5-[(N-methylanilino)methyl]benzimidazol-2-yl]-5-(2-methyl-1,3-oxazol-5-yl)thiophene-2-carboxamide | IC50 | 100.0 [1], 5000.0 [2] |
| N-[5-(Anilinomethyl)-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(2-methyl-1,3-oxazol-5-yl)thiophene-2-carboxamide | IC50 | 11.0 [1], 180.0 [2], 5000.0 [3] |
| N-[5-[[Cyclohexyl(methyl)amino]methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(2-methyl-1,3-oxazol-5-yl)thiophene-2-carboxamide | IC50 | 8.0 [1], 180.0 [2], 670.0 [3] |
| N-[5-[(Cyclohexylamino)methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(2-methyl-1,3-oxazol-5-yl)thiophene-2-carboxamide | IC50 | 8.0 [1], 210.0 [2], 940.0 [3] |
| N-[1-(2-Hydroxy-2-methylpropyl)-5-[(N-methylanilino)methyl]benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 8.0 [1], 120.0 [2], 780.0 [3] |
| N-[5-(Anilinomethyl)-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 2.0 [1], 21.0 [2], 75.0 [3] |
| N-[5-[[Cyclohexyl(methyl)amino]methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 2.0 [1], 13.0 [2], 160.0 [3] |
| N-[5-[(Cyclohexylamino)methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 1.0 [1], 20.0 [2], 99.0 [3] |
| N-[5-(Aminomethyl)-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 4.0 [1], 900.0 [2], 5000.0 [3] |
| N-[1-(2-Hydroxy-2-methylpropyl)-5-(methylaminomethyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 2.0 [1], 420.0 [2], 5000.0 [3] |
| N-[5-[(Dimethylamino)methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 3.0 [1], 26.0 [2], 490.0 [3] |
| N-[5-[(Benzylamino)methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 1.0 [1], 19.0 [2], 140.0 [3] |
| N-[1-(2-Hydroxy-2-methylpropyl)-5-[[methyl(pyridin-3-ylmethyl)amino]methyl]benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 1.0 [1], 6.0 [2], 100.0 [3] |
| N-[5-[(Butan-2-ylamino)methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 2.0 [1], 25.0 [2], 390.0 [3] |
| N-[1-(2-Hydroxy-2-methylpropyl)-5-[(2-methylpropylamino)methyl]benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 1.0 [1], 12.0 [2], 140.0 [3] |
| N-[5-[[[(2R)-3,3-Dimethylbutan-2-yl]amino]methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 1.0 [1], 3.0 [2], 20.0 [3] |
| N-[5-[[[(2R)-3,3-Dimethylbutan-2-yl]-methylamino]methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 1.0 [1], 2.0 [2], 20.0 [3] |
| N-[5-[[[(2S)-3,3-Dimethylbutan-2-yl]-methylamino]methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 1.0 [1], 3.0 [2], 8.0 [3] |
| N-[5-[[2-(Dimethylamino)ethyl-methylamino]methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 2.0 [1], 62.0 [2], 180.0 [3] |
| N-[1-(2-Hydroxy-2-methylpropyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 3.0 [1], 11.0 [2], 250.0 [3] |
| N-[5-[[2-(Hydroxymethyl)piperidin-1-yl]methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 3.0 [1], 58.0 [2], 660.0 [3] |
| N-[5-[(3,5-Dimethylmorpholin-4-yl)methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 1.0 [1], 3.0 [2], 98.0 [3] |
| N-[1-(2-Hydroxy-2-methylpropyl)-5-[(3-hydroxypyrrolidin-1-yl)methyl]benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide | IC50 | 2.0 [1], 130.0 [2], 310.0 [3] |
| 3-[4-Amino-1-[(3S)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(4-propan-2-ylphenyl)benzamide | IC50 | 400.0 [1], 780.0 [2], 1350.0 [3] |
| 3-[4-Amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(4-propan-2-ylphenyl)benzamide | IC50 | 10.0 [1], 40.0 [2], 160.0 [3] |
| 3-[4-Amino-1-(1-prop-2-enoylpiperidin-3-yl)pyrazolo[3,4-d]pyrimidin-3-yl]-N-(3-tert-butylphenyl)benzamide | IC50 | 10.0 [1], 73.0 [2], 2210.0 [3] |
| 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | IC50 | 8510.0 [1] |
| 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | Ki | 26.9 [1] |
| Bms-509744 | IC50 | 19.0 [1] |
| Bms-509744 | Ki | 16.0 [1] |
| Bms-986142 | IC50 | 15.0 [1], 410.0 [2] |
| 2-(1H-Indazol-3-yl)-1H-indole-6-carboxylic acid | IC50 | 3980.0 [1] |
| 3-(6-Methoxy-1H-indol-2-yl)-1H-pyrazolo[4,3-b]pyridine | IC50 | 60.0 [1] |
| N-[1-(3-Amino-3-oxopropyl)-5-[(4,4-difluorocyclohexanecarbonyl)-methylamino]benzimidazol-2-yl]-4-cyanobenzamide | IC50 | 8.0 [1], 2300.0 [2] |
| trans-4-{[4-(1,3-Benzothiazol-2-ylamino)-6-(phenylmethyl)-2-pyrimidinyl]amino}cyclohexanol | Ki | 1.0 [1], 4.0 [2] |
| N-[5-[[3-(4-Acetylpiperazine-1-carbonyl)phenyl]methylsulfanyl]-1,3-thiazol-2-yl]-4-(dimethylamino)benzamide | IC50 | 1000.0 [1] |
| 1-(3-Aminopropyl)-N-cyclohexyl-N-methyl-2-(thiophene-2-carbonylamino)benzimidazole-5-carboxamide | IC50 | 950.0 [1], 20000.0 [2] |
| 1-(3-Amino-3-oxopropyl)-2-[(4-bromobenzoyl)amino]-N-cyclohexyl-N-prop-2-enylbenzimidazole-5-carboxamide | IC50 | 230.0 [1], 1200.0 [2] |
| 1-(3-Amino-3-oxopropyl)-N-cyclohexyl-2-[(4-fluorobenzoyl)amino]-N-methylbenzimidazole-5-carboxamide | IC50 | 250.0 [1], 4100.0 [2] |
| N-Cyclohexyl-N-methyl-1-[3-(methylamino)-3-oxopropyl]-2-(thiophene-2-carbonylamino)benzimidazole-5-carboxamide | IC50 | 160.0 [1], 24000.0 [2] |
| 1-(3-Amino-3-oxopropyl)-N-cyclohexyl-2-[(4-methoxybenzoyl)amino]-N-methylbenzimidazole-5-carboxamide | IC50 | 1100.0 [1], 17000.0 [2] |
| N-Cyclohexyl-1-(3-hydroxypropyl)-N-methyl-2-(thiophene-2-carbonylamino)benzimidazole-5-carboxamide | IC50 | 92.0 [1], 2000.0 [2] |
| Ethyl 3-[5-[cyclohexyl(methyl)carbamoyl]-2-(thiophene-2-carbonylamino)benzimidazol-1-yl]propanoate | IC50 | 270.0 [1], 1100.0 [2] |
| N-Cyclohexyl-N-methyl-1-(2-phenylethyl)-2-(thiophene-2-carbonylamino)benzimidazole-5-carboxamide | IC50 | 1300.0 [1], 1800.0 [2] |
| 1-(3-Amino-3-oxopropyl)-2-[(4-bromobenzoyl)amino]-N-cyclohexyl-N-methylbenzimidazole-5-carboxamide | IC50 | 260.0 [1], 1200.0 [2] |
| N-Cyclohexyl-N-methyl-1-propyl-2-(thiophene-2-carbonylamino)benzimidazole-5-carboxamide | IC50 | 760.0 [1], 1600.0 [2] |
| 1-(3-Amino-3-oxopropyl)-2-benzamido-N-cyclohexyl-N-methylbenzimidazole-5-carboxamide | IC50 | 370.0 [1], 11000.0 [2] |
| 1-(3-Amino-3-oxopropyl)-N-cyclohexyl-N-methyl-2-(pyridine-3-carbonylamino)benzimidazole-5-carboxamide | IC50 | 69.0 [1], 2700.0 [2] |
| 1-(3-Amino-3-oxopropyl)-N-cyclohexyl-2-[(3-fluorobenzoyl)amino]-N-methylbenzimidazole-5-carboxamide | IC50 | 110.0 [1], 7400.0 [2] |
| 1-(5-Amino-5-oxopentyl)-N-cyclohexyl-N-methyl-2-(thiophene-2-carbonylamino)benzimidazole-5-carboxamide | IC50 | 60.0 [1], 3100.0 [2] |
| 1-(3-Amino-3-oxopropyl)-2-benzamido-N-cyclohexyl-N-ethylbenzimidazole-5-carboxamide | IC50 | 390.0 [1], 8100.0 [2] |
| 1-(3-Amino-3-oxopropyl)-2-[(4-cyanobenzoyl)amino]-N-cyclohexyl-N-methylbenzimidazole-5-carboxamide | IC50 | 200.0 [1], 7200.0 [2] |
| N-Cyclohexyl-1-(2-hydroxyethyl)-N-methyl-2-(thiophene-2-carbonylamino)benzimidazole-5-carboxamide | IC50 | 190.0 [1], 4600.0 [2] |
| 1-(3-Amino-3-oxopropyl)-N-cyclohexyl-N-methyl-2-[(4-nitrobenzoyl)amino]benzimidazole-5-carboxamide | IC50 | 76.0 [1], 6900.0 [2] |
| 1-(3-Amino-3-oxopropyl)-2-[(4-bromobenzoyl)amino]-N-cyclohexyl-N-ethylbenzimidazole-5-carboxamide | IC50 | 81.0 [1], 1200.0 [2] |
| 1-(3-Amino-3-oxopropyl)-2-benzamido-N-methyl-N-phenylbenzimidazole-5-carboxamide | IC50 | 330.0 [1], 2600.0 [2] |
| 1-(3-Amino-3-oxopropyl)-N-cyclohexyl-N-methyl-2-(thiophene-2-carbonylamino)benzimidazole-5-carboxamide | IC50 | 110.0 [1], 2700.0 [2] |
| 1-(4-Amino-4-oxobutyl)-N-cyclohexyl-N-methyl-2-(thiophene-2-carbonylamino)benzimidazole-5-carboxamide | IC50 | 140.0 [1], 4600.0 [2] |
| 1-(3-Amino-3-oxopropyl)-2-benzamido-N-cyclohexyl-N-prop-2-enylbenzimidazole-5-carboxamide | IC50 | 730.0 [1], 7200.0 [2] |
| N-[1-(3-Amino-3-oxopropyl)-5-[benzoyl(methyl)amino]benzimidazol-2-yl]-5-pyridin-2-ylthiophene-2-carboxamide | IC50 | 19.0 [1], 650.0 [2] |
| N-[1-(3-Amino-3-oxopropyl)-5-[benzoyl(methyl)amino]benzimidazol-2-yl]-5-phenylthiophene-2-carboxamide | IC50 | 39.0 [1], 820.0 [2] |
| N-[1-(3-Amino-3-oxopropyl)-5-[benzoyl(methyl)amino]benzimidazol-2-yl]-5-pyridin-4-ylthiophene-2-carboxamide | IC50 | 2.0 [1], 510.0 [2] |
| N-[1-[(S)-(1,1-Dioxothiolan-3-yl)-phenylmethyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | IC50 | 25.0 [1] |
| N-[1-[(S)-(1,1-Dioxothiolan-3-yl)-phenylmethyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | Ki | 0.5 [1] |
| N-[1-[(S)-(1,1-Dioxothian-3-yl)-phenylmethyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | IC50 | 36.0 [1] |
| N-[1-[(S)-(1,1-Dioxothian-3-yl)-phenylmethyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | Ki | 0.2 [1] |
| N-[1-[(R)-(1,1-Dioxothian-2-yl)-phenylmethyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | IC50 | 14.0 [1] |
| N-[1-[(R)-(1,1-Dioxothian-2-yl)-phenylmethyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | Ki | 0.3 [1] |
| N-[1-[(S)-(1,1-Dioxothian-4-yl)-phenylmethyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide | IC50 | 60.0 [1] |